| Product Code: ETC6657500 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Genomic Biomarkers Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Genomic Biomarkers Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Genomic Biomarkers Market - Industry Life Cycle |
3.4 Canada Genomic Biomarkers Market - Porter's Five Forces |
3.5 Canada Genomic Biomarkers Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Canada Genomic Biomarkers Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Canada Genomic Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development of genomic biomarkers in Canada |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in genomics leading to the development of innovative biomarkers |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of genomic biomarkers |
4.3.2 High costs associated with genomic testing and analysis |
4.3.3 Limited awareness and adoption of genomic biomarkers among healthcare professionals and patients |
5 Canada Genomic Biomarkers Market Trends |
6 Canada Genomic Biomarkers Market, By Types |
6.1 Canada Genomic Biomarkers Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Canada Genomic Biomarkers Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Canada Genomic Biomarkers Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 Canada Genomic Biomarkers Market Revenues & Volume, By Cardiovascular diseases, 2021- 2031F |
6.1.5 Canada Genomic Biomarkers Market Revenues & Volume, By Neurological diseases, 2021- 2031F |
6.1.6 Canada Genomic Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Canada Genomic Biomarkers Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Canada Genomic Biomarkers Market Revenues & Volume, By Diagnostic and research laboratories, 2021- 2031F |
6.2.3 Canada Genomic Biomarkers Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.4 Canada Genomic Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Genomic Biomarkers Market Import-Export Trade Statistics |
7.1 Canada Genomic Biomarkers Market Export to Major Countries |
7.2 Canada Genomic Biomarkers Market Imports from Major Countries |
8 Canada Genomic Biomarkers Market Key Performance Indicators |
8.1 Rate of adoption of genomic biomarkers in clinical practice |
8.2 Number of collaborations between research institutions and biotechnology companies for biomarker development |
8.3 Investment in genomic biomarker research and development by government and private sector |
8.4 Number of clinical trials incorporating genomic biomarkers |
8.5 Improvement in patient outcomes and treatment efficacy attributed to genomic biomarker utilization |
9 Canada Genomic Biomarkers Market - Opportunity Assessment |
9.1 Canada Genomic Biomarkers Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Canada Genomic Biomarkers Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Canada Genomic Biomarkers Market - Competitive Landscape |
10.1 Canada Genomic Biomarkers Market Revenue Share, By Companies, 2024 |
10.2 Canada Genomic Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |